packageIbrutinib
ibrutinib
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Ibrutinib is a Bruton's tyrosine kinase inhibitor used to treat B-cell blood cancers such as chronic lymphocytic leukemia, mantle cell lymphoma, and other lymphomas. It is an approved medicine, authorised in the European Union, and is widely used in oncology care.
Summary written by glm-5.3-flash from Wikidata Q5984881 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | ibrutinib |
| ATC codes: | L01EL01 |
| DrugBank: | DB09053 |
| PubChem CID: | 24821094 |
| ChEBI: | 76612 |
| Wikidata: | Q5984881 |
| formula: | C25H24N6O2 |
| molar mass: | 440.507 g/mol (PubChem CID 24821094) |
| logP: | 3.6 (Drugs.Common 25.09, not verified) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |